MelaFind (MELA Sciences Inc.) for detection of malignant melanoma
Record ID 32013000230
English
Authors' recommendations:
For Caucasian individuals in the United States, the lifetime probability of developing melanoma of the skin is 1 in 36 for men and 1 in 55 for women. Early detection of melanoma is key in lowering mortality. Estimates of the diagnostic accuracy of dermatologists for discriminating malignant melanoma from benign disease range from 64% to 85%. A successful computer-vision system could remove subjectivity from diagnosis of pigmented skin lesions (PSLs), reduce the number of skin biopsies, and lower the cost of treatment for melanoma by detecting the disease at an earlier stage.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
The report may be purchased from:http://www.hayesinc.com/hayes/crd/?crd=14669
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Melanoma
- Skin Neoplasms
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2012 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.